Sr. Director, Translational Pharmacology and Biology @ (May 2022 - September 2025)
Sr. Director, Translational Medicine @ QED Therapeutics (July 2020 - May 2022)
Director, Translational Medicine @ QED Therapeutics (April 2019 - July 2020)
Sr. Principal Scientist @ (March 2018 - February 2019)
Sr Principal Scientist, Translational Research @ IGNYTA/Roche (January 2016 - March 2018)
Principal Scientist II @ IGNYTA/Roche (January 2014 - December 2015)
Group Leader and Principal Scientist @ (January 2012 - November 2013)
Sr. Scientist II @ (January 2010 - December 2011)
Senior Scientist I @ (August 2007 - December 2009)
Staff Scientist @ (September 2004 - July 2007)
Research Scientist 2 @ Neose Technologies (January 2002 - January 2004)
Postdoctoral Fellow @ (January 2000 - January 2002)
Ge Wei Education
UC Santa Barbara Extension
Woman in Leadership Executive Program
2022-2023
Peking University
Master's degree (Biochemistry)
1999
Peking University
Bachelor's degree (Biochemistry)
1990
Ph.D. (Biochemistry and Molecular Genetics)
Ge Wei Skills
Biochemistry
Assay Development
Protein Purification
Drug Discovery
Protein Expression
Cell Biology
Purification
In Vitro
Molecular Cloning
Protein Chemistry
Clinical Development
In Vivo
Cancer Research
Drug Development
Biomarker Development
Translational oncology
precision medicine
Biotechnology
Life Sciences
Oncology
Cell
DNA
PowerPoint
Research
Microsoft Excel
Science
Customer Service
Microsoft Office
Ge Wei Summary
Ge Wei, based in San Francisco, CA, US, is currently a Executive Director, Biology at Nurix Therapeutics. Ge Wei brings experience from previous roles at Nurix Therapeutics, QED Therapeutics and Bristol-Myers Squibb. Ge Wei holds a 2022 - 2023 Woman in Leadership Executive Program @ UC Santa Barbara Extension. With a robust skill set that includes Biochemistry, Assay Development, Protein Purification, Drug Discovery, Protein Expression and more. Ge Wei has 2 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Ge Wei?
Find contact details for 700 million professionals.